EP1027042A4 - Inhibitoren von farnesyl protein transferase - Google Patents
Inhibitoren von farnesyl protein transferaseInfo
- Publication number
- EP1027042A4 EP1027042A4 EP98948279A EP98948279A EP1027042A4 EP 1027042 A4 EP1027042 A4 EP 1027042A4 EP 98948279 A EP98948279 A EP 98948279A EP 98948279 A EP98948279 A EP 98948279A EP 1027042 A4 EP1027042 A4 EP 1027042A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- inhibitors
- protein transferase
- farnesyl protein
- farnesyl
- transferase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004357 Transferases Human genes 0.000 title 1
- 108090000992 Transferases Proteins 0.000 title 1
- 125000004030 farnesyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])C([H])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US6082397P | 1997-09-29 | 1997-09-29 | |
| US60823P | 1997-09-29 | ||
| PCT/US1998/019315 WO1999018951A1 (en) | 1997-09-29 | 1998-09-16 | Inhibitors of farnesyl protein transferase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EP1027042A1 EP1027042A1 (de) | 2000-08-16 |
| EP1027042A4 true EP1027042A4 (de) | 2004-08-18 |
Family
ID=22031967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP98948279A Withdrawn EP1027042A4 (de) | 1997-09-29 | 1998-09-16 | Inhibitoren von farnesyl protein transferase |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1027042A4 (de) |
| JP (1) | JP2001519387A (de) |
| AU (1) | AU735366B2 (de) |
| CA (1) | CA2304473A1 (de) |
| WO (1) | WO1999018951A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458783B1 (en) * | 1997-09-29 | 2002-10-01 | Bristol-Myers Squibb Company | Non-imidazole benzodiazepine inhibitors of farnesyl protein transferase |
| HRP990246A2 (en) | 1998-08-07 | 2000-06-30 | Du Pont Pharm Co | Succinoylamino benzodiazepines as inhibitors of a beta protein production |
| NZ525513A (en) | 1998-08-07 | 2004-09-24 | Pont Pharmaceuticals Du | Succinoylamino lactams as inhibitors of Abeta protein production |
| CN1636011A (zh) | 1998-12-24 | 2005-07-06 | 杜邦药品公司 | 作为Aβ蛋白产生抑制剂的琥珀酰氨基苯并二氮杂䓬 |
| AU5497000A (en) * | 1999-06-18 | 2001-01-09 | Ramot University Authority For Applied Research And Industrial Development Ltd. | Non-malignant disease treatment with ras antagonists |
| US20020115696A1 (en) | 1999-06-18 | 2002-08-22 | Yoel Kloog | Treatment of post-angioplasty restenosis and atherosclerosis with ras antagonists |
| FR2796943A1 (fr) * | 1999-07-30 | 2001-02-02 | Aventis Pharma Sa | Derives de benzoxazinnes, leur procede de preparation et leur utilisation en therapeutique |
| US6960576B2 (en) | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
| US6503902B2 (en) | 1999-09-13 | 2003-01-07 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of a β protein production |
| EP1222176A1 (de) | 1999-10-08 | 2002-07-17 | Bristol-Myers Squibb Pharma Company | Amino-laktam-sulfonamide als inhibitoren der bildung von a-beta-protein |
| EP1261610A2 (de) | 2000-02-17 | 2002-12-04 | Bristol-Myers Squibb Pharma Company | Succinoylamino-carbocyclen und -heterocyclen als hemmer der a-beta-proteinbildung |
| EP1268434A1 (de) | 2000-04-03 | 2003-01-02 | Bristol-Myers Squibb Pharma Company | Zyklische lactame als a-beta proteinproduktionsinhibitoren |
| MXPA02009755A (es) | 2000-04-03 | 2003-03-27 | Bristol Myers Squibb Pharma Co | Lactamas ciclicas como inhibidores de la produccion de proteina a-beta. |
| WO2001077086A1 (en) | 2000-04-11 | 2001-10-18 | Dupont Pharmaceuticals Company | SUBSTITUTED LACTAMS AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| IL147629A0 (en) | 2000-06-01 | 2002-08-14 | Bristol Myers Squibb Pharma Co | LACTAMS SUBSTITUTED BY CYCLIC SUCCINATES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| EP1443936A4 (de) * | 2001-11-13 | 2006-01-11 | Bristol Myers Squibb Co | Verfahren zur herstellung von 3,7-disubstituierten-2,3,4,5- tetrahydro-1h-1,4-benzodiazepin-verbindungen |
| CA2559285A1 (en) * | 2004-03-18 | 2005-09-29 | Brigham And Women's Hospital, Inc. | Methods for the treatment of synucleinopathies |
| JP2008539276A (ja) * | 2005-04-27 | 2008-11-13 | ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイティド | ヒト疾患に関連する変異体タンパク質の分解能を改善するための材料及び方法 |
| BRPI0811204A8 (pt) | 2007-05-10 | 2015-09-22 | Bristol Myers Squibb Co | Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina |
| WO2013023059A2 (en) | 2011-08-10 | 2013-02-14 | Lankenau Institute For Medical Research | Methods and compositions for the treatment of autoimmune and inflammatory diseases |
| BR122019007990B1 (pt) | 2013-11-18 | 2021-05-04 | Forma Therapeutics, Inc | Composto, e, composição farmacêutica |
| RU2720237C2 (ru) | 2013-11-18 | 2020-04-28 | Форма Терапеутикс, Инк. | Композиции, содержащие бензопиперазин, в качестве ингибиторов бромодоменов вет |
| PL3445744T3 (pl) * | 2016-04-18 | 2022-02-07 | Vivoryon Therapeutics Ag | Nowe inhibitory mepryny alfa i beta |
| JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
| JP7050165B2 (ja) | 2018-02-26 | 2022-04-07 | ギリアード サイエンシーズ， インコーポレイテッド | Ｈｂｖ複製阻害剤としての置換ピロリジン化合物 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6011029A (en) * | 1996-02-26 | 2000-01-04 | Bristol-Myers Squibb Company | Inhibitors of farnesyl protein transferase |
-
1998
- 1998-09-16 EP EP98948279A patent/EP1027042A4/de not_active Withdrawn
- 1998-09-16 WO PCT/US1998/019315 patent/WO1999018951A1/en not_active Ceased
- 1998-09-16 CA CA002304473A patent/CA2304473A1/en not_active Abandoned
- 1998-09-16 JP JP2000515586A patent/JP2001519387A/ja active Pending
- 1998-09-16 AU AU94886/98A patent/AU735366B2/en not_active Ceased
Non-Patent Citations (1)
| Title |
|---|
| No further relevant documents disclosed * |
Also Published As
| Publication number | Publication date |
|---|---|
| AU735366B2 (en) | 2001-07-05 |
| CA2304473A1 (en) | 1999-04-22 |
| EP1027042A1 (de) | 2000-08-16 |
| WO1999018951A1 (en) | 1999-04-22 |
| AU9488698A (en) | 1999-05-03 |
| JP2001519387A (ja) | 2001-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0004148A3 (en) | Inhibitors of farnesyl protein transferase | |
| IL124197A (en) | Inhibitors of farnesyl protein transferase | |
| IL126833A0 (en) | Inhibitors of protein farnesyl transferase | |
| EP0918771A4 (de) | Thiadioxobenzodiazepin-inhibitoren der farnesyl-protein-transferase | |
| EP0696593A3 (de) | Inhibitoren der farnesyl protein Transferase | |
| AU5772698A (en) | Inhibitors of farnesyl protein transferase | |
| HU9500934D0 (en) | Imidazole-containing inhibitors of farnesyl protein transferase | |
| PH11998001073B1 (en) | Inhibitors of protein isoprenyl transferases | |
| IL143409A0 (en) | Farnesyl protein transferase inhibitors | |
| AU5164898A (en) | Thioproline-containing inhibitors of farnesyl protein transferase | |
| ZA985203B (en) | Compounds useful for inhibition of farnesyl protein transferase | |
| HUP0202152A2 (en) | Tricyclyc farnesyl protein transferase inhibitors | |
| AU4329397A (en) | Semipeptoid farnesyl protein transferase inhibitors and analogs thereof | |
| ZA985210B (en) | Compounds for the inhibition of farnesyl protein transferase | |
| GB9223250D0 (en) | Inhibitors of farnesyl protein transferase | |
| HUP9903221A3 (en) | Inhibitors of protein farnesyl transferase | |
| ZA971621B (en) | Inhibitors of farnesyl protein transferase | |
| HK1027561A (en) | Inhibitors of farnesyl protein transferase | |
| IL133388A0 (en) | Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase | |
| HUP0002186A3 (en) | Compounds useful for inhibition of farnesyl protein transferase | |
| IL149870A0 (en) | Inhibitors of farnesyl protein transferase | |
| SG28242A1 (en) | Imidazole-containing inhibitors of farnesyl protein transferase | |
| ZA952696B (en) | Imidazole-containing inhibitors of farnesyl protein transferase | |
| IL141626A0 (en) | Farnesyl transferase inhibitors | |
| GB9609981D0 (en) | Inhibitors of farnesyl-protien transferase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20000427 |
|
| AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
| A4 | Supplementary search report drawn up and despatched |
Effective date: 20040706 |
|
| RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7A 61P 35/00 B Ipc: 7C 07D 403/06 B Ipc: 7C 07D 403/12 B Ipc: 7C 07D 401/12 B Ipc: 7C 07D 409/06 B Ipc: 7C 07D 401/06 B Ipc: 7C 07D 243/14 B Ipc: 7C 07D 243/12 B Ipc: 7C 07D 241/36 B Ipc: 7C 07D 239/70 B Ipc: 7C 07D 237/26 B Ipc: 7A 61K 31/55 B Ipc: 7A 61K 31/54 B Ipc: 7A 61K 31/535 B Ipc: 7A 61K 31/53 B Ipc: 7A 61K 31/50 B Ipc: 7A 61K 31/495 B Ipc: 7A 61K 31/33 A |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20060331 |